NCT01967628View on ClinicalTrials.gov

Human Lung Responses to Respiratory Pathogens

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2010

Conditions
Respiratory Infection
Interventions
DIETARY_SUPPLEMENT

Vitamin D3 (cholecalciferol)

DIETARY_SUPPLEMENT

Placebo Sugar Pill

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Iowa

OTHER

NCT01967628 - Human Lung Responses to Respiratory Pathogens | Biotech Hunter | Biotech Hunter